The Yonsei University Health System is implementing a government-funded initiative called Connect-DTx. This platform uses digital therapeutics and big data to unite hospitals, government, insurers, and medical device manufacturers in the care process to provide personalised treatments. Connect-DTx collects near real-time health data from patients, streamlines insurance claims, and allows manufacturers to track the use of their products at health institutions. Several hospitals are onboarding the system and more applications for different conditions will be launched soon.
At ASCO, Merck KGaA Shows How Its Drug Measures Up as Treatment for Rare Type of Tumor
Merck KGaA says its once-daily pill, pimicotinib, designed to inhibit the overexpression of CSF-1, a protein contributing to tenosynovial giant cell tumor (TGCT) growth, showed
